drugset / Trial / NCT00910793

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients

NCT00910793

Phase 4 Completed 29 enrolled Wilfried De Backer UCB Pharma · collab
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to evaluate the effect of the combination of formoterol and beclometasone dipropionate on central and peripheral airway dimensions in asthmatic patients using Computational Fluid Dynamics (CFD). Further more, the effect of this combination therapy on exhaled NO, lung function (spirometry, body plethysmography, diffusion and resistance) and subjective asthma control score as well as the safety of this combination will be assessed.

Timeline

Start
2008-08
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 6 ug Inhaled
Subject beclomethasone dipropionate Other / unclassified 100 ug Inhaled

Indications